Idexx Laboratories (IDXX) financials
Idexx Laboratories revenue and earnings by year
Idexx Laboratories's revenue was $4.30 billion in the fiscal year to December 31, 2025, up 10.4% from the year before. Net income was $1.06 billion, 24.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 10.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.30 | 3.90 | 3.66 | 3.37 | 3.22 | 2.71 | 2.41 | 2.21 | 1.97 | 1.78 |
| Revenue growth | 10.4% | 6.5% | 8.7% | 4.7% | 18.8% | 12.5% | 8.8% | 12.4% | 10.9% | — |
| Gross profit | 2.66 | 2.38 | 2.19 | 2.00 | 1.89 | 1.57 | 1.37 | 1.24 | 1.10 | 0.98 |
| Gross margin | 61.8% | 61.0% | 59.8% | 59.5% | 58.8% | 58.0% | 56.7% | 56.1% | 55.7% | 54.9% |
| Operating income | 1.36 | 1.13 | 1.10 | 0.90 | 0.93 | 0.69 | 0.55 | 0.49 | 0.41 | 0.35 |
| Operating margin | 31.6% | 29.0% | 30.0% | 26.7% | 29.0% | 25.7% | 23.0% | 22.2% | 21.0% | 19.7% |
| Net income | 1.06 | 0.89 | 0.85 | 0.68 | 0.74 | 0.58 | 0.43 | 0.38 | 0.26 | 0.22 |
| Net margin | 24.6% | 22.8% | 23.1% | 20.2% | 23.2% | 21.5% | 17.8% | 17.0% | 13.4% | 12.5% |
| Diluted EPS | $13.08 | $10.67 | $10.06 | $8.03 | $8.60 | $6.71 | $4.88 | $4.27 | $2.94 | $2.45 |
| Free cash flow | 1.04 | 0.80 | 0.77 | 0.38 | 0.64 | 0.54 | 0.30 | 0.28 | 0.30 | 0.27 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open IDXX in Markets.
How Idexx Laboratories makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Product | $719M | 59.1% |
| Services | $498M | 40.9% |
See also: IDXX valuation and P/E history · IDXX returns
No forecast, no recommendation. This page describes Idexx Laboratories from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.